MedTrace Logo

Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration

NCT00896636 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 385

Last updated 2020-08-31

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and breast tissue from healthy women in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to breast cancer risk.

PURPOSE: This research study is looking at breast tissue in women not previously diagnosed with breast cancer who are undergoing fine-needle aspiration.

Conditions

Interventions

PROCEDURE

Random fine need aspiration (rFNA)

Deep infiltration into the tissue of each breast with up to a 21 gauge needle attached to a syringe with about 4-5 passes at each location (up to 8-10 passes per breast) under local anesthesia (lidocaine).

OTHER

Mammogram

Standard mammography of both breasts to obtain images for breast density measurement.

Sponsors & Collaborators

Principal Investigators

  • Seema A. Khan, MD · Robert H. Lurie Cancer Center

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-20
Primary Completion
2013-01-18
Completion
2022-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00896636 on ClinicalTrials.gov